Actively Recruiting
Intranasal Insulin for Posttraumatic Stress Disorder
Led by VA Connecticut Healthcare System · Updated on 2025-09-16
20
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
CONDITIONS
Official Title
Intranasal Insulin for Posttraumatic Stress Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female, 21-65 years old
- Current PTSD
- Able to provide written informed consent
You will not qualify if you...
- Unstable medical condition, clinically determined by a physician
- Diabetes requiring insulin or oral hypoglycemic agents
- Moderate-severe traumatic brain injury
- Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months
- Current substance use disorders (except alcohol, tobacco, or cannabis) in the past 3 months
- Changes in doses of psychotropic medications in the past 4 weeks
- Initiation of individual therapy or counseling in the past 4 weeks
- Imminent suicidal or homicidal risk
- Contraindication to Insulin
- History of claustrophobia
- Presence of cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies in vulnerable positions as assessed by a standard pre-MRI safety screening questionnaire
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516
Actively Recruiting
Research Team
G
Gihyun Yoon, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here